ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value ($000): $758,849 (100.0% shares, 0.0% debt)

Holdings (20)

QUIDEL CORP 51.9%
Value ($000) $393,889 Shares 1,795,462 Est. Cost $24542.18 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 17.8%
Value ($000) $134,883 Shares 2,074,800 Est. Cost $49.53 Unrealized
AGENUS INC 6.9%
Value ($000) $52,540 Shares 13,134,900 Est. Cost $3.47 Unrealized
OPK OPKO HEALTH INC 6.5%
Value ($000) $49,283 Shares 13,355,773 Est. Cost $3.45 Unrealized +22.2%
ACCELERATE DIAGNOSTICS INC 5.7%
Value ($000) $43,618 Shares 4,091,749 Est. Cost $22.26 Unrealized
ASPIRA WOMENS HEALTH INC 3.5%
Value ($000) $26,678 Shares 8,647,774 Est. Cost $3.84 Unrealized
PACB PACIFIC BIOSCIENCES CALIF IN 2.2%
Value ($000) $16,991 Shares 1,721,459 Est. Cost $4.92 Unrealized +17.0%
SOLENO THERAPEUTICS INC 1.2%
Value ($000) $9,213 Shares 3,670,384 Est. Cost $1.78 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 1.1%
Value ($000) $8,676 Shares 2,525,857 Est. Cost $4.05 Unrealized +5.7%
QUIDEL CORP 0.9%
Value ($000) $6,646 Shares 228,000 Est. Cost $24542.18 Unrealized
ANTARES PHARMA INC 0.6%
Value ($000) $4,589 Shares 1,699,566 Est. Cost $3.19 Unrealized
AMARIN CORP PLC 0.6%
Value ($000) $4,275 Shares 1,015,501 Est. Cost $494.19 Unrealized
MOTUS GI HLDGS INC 0.5%
Value ($000) $3,721 Shares 3,806,666 Est. Cost $3.08 Unrealized
BIIB BIOGEN INC 0.1%
Value ($000) $1,046 Shares 3,688 Est. Cost $213.68 Unrealized +30.5%
Y-MABS THERAPEUTICS INC 0.1%
Value ($000) $968 Shares 25,212 Est. Cost $26.10 Unrealized
CONTRAFECT CORP 0.1%
Value ($000) $885 Shares 167,587 Est. Cost $5.65 Unrealized
BIOLASE INC 0.1%
Value ($000) $478 Shares 1,739,100 Est. Cost $1.21 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 0.1%
Value ($000) $423 Shares 68,100 Est. Cost $49.53 Unrealized
AGENUS INC 0.0%
Value ($000) $39 Shares 105,200 Est. Cost $3.47 Unrealized
AMARIN CORP PLC 0.0%
Value ($000) $8 Shares 305,300 Est. Cost $494.19 Unrealized